Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
The Journal of Clinical Investigation|December 19, 2002
Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targetingValérie Dutoit, Robert N Taub, Kyriakos P Papadopoulos, et al.Cancer Immunity|October 10, 2003
SSX antigens as tumor vaccine targets in human sarcomaMaha Ayyoub, Michelle Brehm, Geneviève Metthez, et al.Cancer Research|March 26, 2002
Circulating Tumor-reactive CD8(+) T cells in melanoma patients contain a CD45RA(+)CCR7(-) effector subset exerting ex vivo tumor-specific cytolytic activityDanila Valmori, Carmen Scheibenbogen, Valerie Dutoit, et al.Cancer Research|June 4, 2009
Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancerFeng Qian, Jeannine Villella, Paul K Wallace, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigenPierre-Yves Dietrich, Frédérique-Anne Le Gal, Valérie Dutoit, et al.Immunological Reviews|November 26, 2002
Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanomaPedro Romero, Danila Valmori, Mikael J Pittet, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingDanila Valmori, Naira E Souleimanian, Valeria Tosello, et al.Cancer Research|November 8, 2013
Regulation of CD4(+)NKG2D(+) Th1 cells in patients with metastatic melanoma treated with sorafenib: role of IL-15Rα and NKG2D triggeringAna I Romero, Nathalie Chaput, Vichnou Poirier-Colame, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular CarcinomaMarkus W Löffler, Stefania Gori, Francesco Izzo, et al.Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8+ T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.Pageof 8